The medical landscape in 2026 is witnessing a significant evolution in vascular access, with the global value of subcutaneous access solutions reaching an estimated $3.29 billion. For patients undergoing intensive treatments like chemotherapy or long-term antibiotic therapy, the move toward "power-injectable" ports has become the 2026 standard of care. Unlike older models, these 2026-gen...
จองคิวบริการ
NR tours
Youplay
NR shop
NR jobs
facebook th
Spanish 
thai
English
French
Portuguese
Italiano
Romaian
Portuguese (Brazil)
china